Softwr

Healthcare · head to head

Paige vs TheraNest

Paige logo

Paige

Healthcare

Digital pathology AI holding the first FDA De Novo authorisation for a pathology algorithm, now part of Tempus

From
On request
Rated
-
Full reviewWebsite
TheraNest logo

TheraNest

Healthcare

Mental health EHR and practice management priced per therapist

From
$29/month
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Paige the FDA authorisation is confined to prostate core needle biopsies, on compatible scanners, viewed through FullFocus, as an adjunct only; every other tissue type and every grading claim is outside that authorisation in the United States.; TheraNest the Essentials plan includes no insurance claims at all, so any practice that bills a payer is effectively on the 59 USD tier or above and the advertised 29 USD entry price does not apply to it.
  • They diverge on capability: Paige covers Paige Prostate Detect, TheraNest covers Progress notes and treatment plans.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Paige and TheraNest actually diverge.

Attributes where Paige and TheraNest differ
AttributePaigeTheraNest
Starting priceOn request$29/month
Pricing modelquotePer user per month
PlatformsWeb, Cloud, On-premiseWeb, iOS, Android

Identical on both: free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Paige

  • Paige Prostate Detect
  • Paige Prostate Grade and Quantify
  • Perineural invasion detection
  • Breast and lymph node applications
  • FullFocus viewer
  • Foundation models
  • OmniScreen
  • Paige Alba

Only in TheraNest

  • Progress notes and treatment plans
  • Insurance claims
  • Client portal
  • Telehealth
  • Group and family sessions
  • Payroll and staff reporting

What people use each for

The jobs each tool is most often brought in to do.

Paige

  • A reference laboratory processing high volumes of prostate core needle biopsies where a second read on every case is not staffablenot TheraNest
  • A pathology department already digitised that wants a documented safety net against missed small foci of cancernot TheraNest
  • A hospital laboratory struggling to recruit uropathology subspecialists and needing consistency across generalist reportingnot TheraNest
  • A pharmaceutical company needing consistent biomarker scoring across trial sites rather than site-by-site pathologist variabilitynot TheraNest

TheraNest

  • A solo therapist who needs a HIPAA aligned note and scheduling system and does not bill insurance, where the 29 USD entry tier is genuinely sufficientnot Paige
  • A group practice of six to twenty clinicians that wants per clinician productivity and payroll reporting without buying a separate practice management layernot Paige
  • A practice moving off paper or a general purpose calendar that needs a client portal for intake forms and consent signaturesnot Paige
  • A behavioural health organisation that bills a steady volume of insurance claims each month and can size the Advanced allowance against its actual claim countnot Paige

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Paige

  • The FDA authorisation is confined to prostate core needle biopsies, on compatible scanners, viewed through FullFocus, as an adjunct only; every other tissue type and every grading claim is outside that authorisation in the United States.
  • The algorithm is worthless without a digital pathology programme already running, and slide scanning, storage and workflow typically cost far more than the software licence.
  • Tempus acquired Paige in 2025, so the roadmap now competes for attention inside a genomics-led business, and the pathology-only buyer is no longer the primary customer.
  • Scanner compatibility is a hard constraint rather than a preference, and a laboratory with an unsupported scanner fleet cannot use the authorised indication at all.
  • Pricing is per case or per slide and unpublished, so a laboratory cannot model cost per reported case without entering a sales process.

TheraNest

  • The Essentials plan includes no insurance claims at all, so any practice that bills a payer is effectively on the 59 USD tier or above and the advertised 29 USD entry price does not apply to it.
  • Telehealth is only in the Premier plan, so a practice that wants video sessions pays 89 USD per therapist per month even if it needs nothing else from that tier.
  • An annual AMA CPT licence fee is billed separately each December on top of subscription cost, which surprises practices that budgeted only the monthly figure.
  • Additional administrative users are chargeable, so a practice with front desk and billing staff who never see clients still pays 19 to 29 USD per head for people who generate no revenue.
  • The product sits inside a consolidated portfolio that has already renamed the parent company from Therapy Brands to Ensora Health, and product investment in a portfolio is directed by the owner rather than by this product line, so roadmap commitments are worth less than they would be from a single product vendor.

Pricing, plan by plan

Paige

On request
  • Paige clinical applications$undefined/year
    • Priced per case or per slide analysed under annual agreement
    • Prostate, breast and other applications licensed separately
    • Requires compatible whole slide scanner and the FullFocus viewer for the authorised indication

TheraNest

$29/month
  • Essentials$29/month
    • Per therapist
    • Scheduling and client portal
    • HIPAA aligned notes and documentation
  • Advanced$59/month
    • Per therapist
    • 30 insurance claims per month included
    • Custom forms
  • Premier$89/month
    • Per therapist
    • Unlimited insurance claims
    • Billing automation

Which should you pick?

Choose Paige if

  • You need paige prostate detect.
  • You work on Web, Cloud, On-premise.
  • You also want paige prostate grade and quantify.
Paige review

Choose TheraNest if

  • You need progress notes and treatment plans.
  • You work on Web, iOS, Android.
  • You also want insurance claims.
TheraNest review

Questions people ask

Is Paige or TheraNest better?
Neither clearly leads. Paige starts at On request and TheraNest at $29/month, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Paige or TheraNest?
Paige starts at On request and TheraNest at $29/month.
Does Paige or TheraNest run on more platforms?
Paige runs on Web, Cloud, On-premise. TheraNest runs on Web, iOS, Android.
What is Paige best used for?
Paige is most often used for a reference laboratory processing high volumes of prostate core needle biopsies where a second read on every case is not staffable, a pathology department already digitised that wants a documented safety net against missed small foci of cancer, a hospital laboratory struggling to recruit uropathology subspecialists and needing consistency across generalist reporting, a pharmaceutical company needing consistent biomarker scoring across trial sites rather than site-by-site pathologist variability. Of those, a reference laboratory processing high volumes of prostate core needle biopsies where a second read on every case is not staffable and a pathology department already digitised that wants a documented safety net against missed small foci of cancer are not what TheraNest is typically brought in for.
What can Paige do that TheraNest cannot?
Paige covers Paige Prostate Detect, Paige Prostate Grade and Quantify, Perineural invasion detection, Breast and lymph node applications. TheraNest covers Progress notes and treatment plans, Insurance claims, Client portal, Telehealth.

Answered from the vendors’ own pages

Paige: What exactly is FDA authorised?

Paige Prostate Detect, as an adjunct for identifying areas of interest on digitised prostate core needle biopsy slides, viewed through the Paige FullFocus viewer on a compatible scanner. Nothing else in the portfolio holds that authorisation in the United States.

TheraNest: Is TheraNest still sold under that name?

Yes. The company rebranded from Therapy Brands to Ensora Health and the product is now marketed as TheraNest by Ensora Health, but you still buy TheraNest.

Paige: Is the European position broader?

Yes. The Paige Prostate suite including grading and quantification received IVDR certification in 2025, which covers more than the United States authorisation.

TheraNest: Can I bill insurance on the cheapest plan?

No. Essentials includes no claims. Advanced includes 30 claims a month and Premier is unlimited.

Paige: What did the pivotal study measure?

Pathologist cancer detection on individual slide images improved, with reported reductions in false negative and false positive readings. It measured pathologist performance with the tool, not standalone algorithm accuracy.

TheraNest: Are there hidden costs?

Two. Additional admin users are charged per head, and an AMA CPT licence fee is billed annually in December per therapist.

Paige: Who owns Paige now?

Tempus AI acquired Paige in 2025. Products remain branded Paige.

TheraNest: Does it support group practices?

Yes, with per clinician reporting and payroll figures, though every clinician and every admin is a paid seat.

Share

Related pages

More on Paige

More on TheraNest

Keep looking

Other head to heads